Latest Share Price Movement News

Global Lithium Resources Limited has clarified that recent spikes in its share price and trading volume are linked to previously announced project developments, not undisclosed information.

Deterra Royalties Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.13 per share for the half-year ending June 2025, alongside a recalculated Dividend Reinvestment Plan price.

Dateline Resources has responded to an ASX Aware Letter confirming the materiality of its recent gold exploration disclosures and its adherence to continuous disclosure rules.

Sunrise Energy Metals has addressed ASX concerns over recent share price volatility, confirming no undisclosed material information beyond announced scandium assay results. An updated Mineral Resource Estimate and Feasibility Study for the Syerston project are expected imminently.

Rubix Resources (ASX, RB6) has resumed trading after lifting its suspension, following key announcements on its drilling program, capital raising, and a proposed acquisition.

333D Limited has responded to ASX queries, clarifying that its Bitcoin Treasury Management Policy approval is not price sensitive, while disclosing a $370,500 Bitcoin acquisition funded partly by R&D tax incentives.

IPH Limited has clarified that its FY25 underlying earnings aligned closely with market consensus, addressing ASX concerns amid a notable share price drop post-results. The company attributes the share price movement to external operational challenges rather than earnings surprises.

DigiCo Infrastructure REIT confirms its FY25 EBITDA slightly exceeded IPO guidance and aligned with analyst forecasts, attributing recent share price declines to the absence of FY26 earnings guidance.

Argo Global Listed Infrastructure Limited has announced the renewal of its on-market buy-back facility, allowing the repurchase of up to 8.9 million ordinary shares over the next year starting September 2025.

Westgold Resources Limited has announced an on-market buy-back of up to 47.18 million shares, signaling a strategic move to manage capital and potentially boost shareholder value.

ClearView Wealth Limited reported a solid 10% revenue increase for FY25 alongside a 126% jump in profit from continuing operations, yet net profit was tempered by losses from discontinued segments. The company paused its share buy-back program, signaling cautious capital management ahead.

Optiscan Imaging Limited has launched a $17.75 million fully underwritten entitlement offer to fund clinical trials, regulatory approvals, and product development. Peters Investments underwrites the offer, potentially increasing its stake to nearly 39%.